Humana Inc. (BMV:HUM)
Mexico · Delayed Price · Currency is MXN | Market Cap | 760.74B +44.8% |
| Revenue (ttm) | 2.47T +14.1% |
| Net Income | 20.37B -33.9% |
| EPS | 168.70 -33.9% |
| Shares Out | n/a |
| PE Ratio | 37.34 |
| Forward PE | 33.65 |
| Dividend | 64.67 (1.01%) |
| Ex-Dividend Date | Mar 27, 2026 |
| Volume | 12 |
| Open | 6,400.00 |
| Previous Close | n/a |
| Day's Range | 6,400.00 - 6,400.00 |
| 52-Week Range | 2,941.00 - 6,400.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 29, 2026 |
About Humana
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and... [Read more]
Financial Performance
In 2025, Humana's revenue was $129.66 billion, an increase of 10.11% compared to the previous year's $117.76 billion. Earnings were $1.19 billion, a decrease of -1.57%.
Financial numbers in USD Financial StatementsNews
Report shows Medicare plans often deny access to special care, NY Times says
According to new reports from the inspector general’s office at the Department of Health and Human Services focusing on major health insurers, UnitedHealth (UNH), Humana (HUM), and CVS Health (CVS),…
Humana To Divest End-Of-Life Care Business For $900 Million
Humana, one of the nation's largest providers of privatized Medicare Advantage health insurance for older adults, announced plans to divest its minority stake in a provider of end-of-life services for...
Humana divests minority stake in hospice provider Gentiva
Humana said on Wednesday it has agreed to sell all or substantially all of its minority stake in Gentiva, a provider of hospice and palliative care services, in a deal valuing the stake at about $9...
Humana to divest minority interest in Gentiva to consortium of investors
Humana (HUM) announced that it has signed a definitive agreement with a consortium of investors to divest all or substantially all of its minority interest in Gentiva, a provider of…
Humana Announces Agreement to Divest Minority Interest in Gentiva
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced that it has signed a definitive agreement with a consortium of investors to divest all or substantially all of its minority in...
Humana and CenterWell Employees Donate More Than $1.4 Million in 24 Hours
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana and CenterWell employees combined to donate more than $1.4 million to nonprofit organizations in just 24 hours during the Humana Foundation's annual Double Mat...
As Tech Stocks Slide, The Healthcare Sector Shines. Why Some Experts Say They Like This Defensive Play
Tech stocks are pulling back, and healthcare is surging.
Humana price target raised to $316 from $214 at JPMorgan
JPMorgan analyst Lisa Gill raised the firm’s price target on Humana (HUM) to $316 from $214 and keeps a Neutral rating on the shares. The firm updated healthcare service models.
Humana price target raised to $390 from $335 at Mizuho
Mizuho raised the firm’s price target on Humana (HUM) to $390 from $335 and keeps an Outperform rating on the shares. The firm believes the managed care sector is entering…
Medicare Advantage Continues To Grow Despite Health Insurer Exits
Despite some high-profile retreats by health insurers from Medicare Advantage, the privatized medical coverage for older adults continues to add health plan members and is now the choice of 55% of eli...
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
No tech, no problem. Dow makes record and traders think these stocks can lead now
Traders bought about 5,300 calls in the State Street Health Care Select Sector SPDR ETF (XLV) on Thursday, compared to just over 1,000 puts, according to data from ThinkOrSwim.
Humana price target raised to $249 from $217 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Humana (HUM) to $249 from $217 and keeps an Underweight rating on the shares. Managed care stocks have been “grinding higher” on…
Humana price target raised to $340 from $267 at BofA
BofA raised the firm’s price target on Humana (HUM) to $340 from $267 and keeps a Neutral rating on the shares. Data points continue to trickle in pointing to cost…
Humana price target raised to $425 from $288 at Bernstein
Bernstein analyst Lance Wilkes raised the firm’s price target on Humana (HUM) to $425 from $288 and keeps an Outperform rating on the shares. The firm sees attractive EPS upside…
Humana price target raised to $320 from $270 at Truist
Truist analyst David MacDonald raised the firm’s price target on Humana (HUM) to $320 from $270 and keeps a Hold rating on the shares as part of a broader research…
Humana backs FY26 adjusted EPS view ‘at least’ $9.00, consensus $8.84
Members of Humana’s (HUM) senior management team are scheduled to meet with investors and analysts at various meetings between June 1 and June 30. During these meetings, the company intends…
Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM
NEW ORLEANS, May 29, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
Humana completes $83M Florida infrastructure investment
Humana (HUM) announced the start of full operations of its newest CenterWell Pharmacy mail order distribution center, in Orlando, Florida. The $83M facility bolsters capacity for prescription medicati...
Humana completes $83 million Florida infrastructure investment to deepen coordinated patient care approach
ORLANDO, Fla.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM), one of the nation's leading health and well-being companies, today announced the start of full operations of its newest CenterWell Pharmacy® ma...
Humana price target raised to $344 from $180 at Barclays
Barclays raised the firm’s price target on Humana (HUM) to $344 from $180 and keeps an Equal Weight rating on the shares. The firm believes the managed care stock moves…
Humana price target raised to $320 from $262 at UBS
UBS raised the firm’s price target on Humana (HUM) to $320 from $262 and keeps a Neutral rating on the shares. Managed care organizations broadly raised guidance after stronger-than-expected Q1…
Easing medical costs a positive for health insurers, but real test lies ahead, analysts say
U.S. health insurers' strong first-quarter results signaled more stable medical costs after prolonged pressure, but Wall Street analysts want to see another similar quarter before they are convinced.
Humana Invests More Than $1 Million to Advance Health Outcomes Across Louisiana
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana invests more than $1 million to advance health outcomes across Louisiana through grants that support statewide priorities.